SHEPHERD KAPLAN KROCHUK, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 101 filers reported holding CARA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
SHEPHERD KAPLAN KROCHUK, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$391,000
+20.7%
31,585
+19.3%
0.24%
+18.4%
Q4 2017$324,000
-55.3%
26,468
-50.0%
0.20%
-66.6%
Q3 2017$725,000
-11.0%
52,9370.0%0.60%
+26.5%
Q2 2017$815,000
-16.3%
52,9370.0%0.48%
-5.2%
Q1 2017$974,000
+20.0%
52,937
-39.4%
0.50%
+116.9%
Q4 2016$812,000
-39.9%
87,379
-46.0%
0.23%
-17.8%
Q3 2016$1,350,000
+48.5%
161,689
-14.4%
0.28%
+24.3%
Q2 2016$909,000
+3.1%
188,974
+33.2%
0.23%
-17.5%
Q1 2016$882,000
-17.6%
141,857
+123.5%
0.27%
-2.8%
Q4 2015$1,070,000
-34.7%
63,458
-44.6%
0.28%
-35.2%
Q3 2015$1,638,000
-0.8%
114,633
-15.6%
0.44%
+40.3%
Q2 2015$1,651,000
+20.9%
135,8750.0%0.31%
+28.1%
Q1 2015$1,366,000
+24.7%
135,875
+23.7%
0.24%
+37.5%
Q4 2014$1,095,000
+14.1%
109,816
-4.0%
0.18%
+43.1%
Q3 2014$960,000
-5.4%
114,397
+91.8%
0.12%
+13.9%
Q2 2014$1,015,000
+2.5%
59,657
+12.1%
0.11%
-5.3%
Q1 2014$990,00053,2100.11%
Other shareholders
CARA THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,799,058$42,350,00022.29%
Chescapmanager LLC 1,314,603$19,890,0002.42%
Prosight Management, LP 294,041$4,449,0002.06%
DAFNA Capital Management LLC 261,442$3,956,0001.18%
Cypress Capital Management LLC (WY) 81,269$1,230,0001.06%
KINGDON CAPITAL MANAGEMENT, L.L.C. 626,583$9,480,0001.02%
Carmignac Gestion 1,851,443$28,012,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 2,465,000$37,295,0000.22%
Ikarian Capital, LLC 301,700$4,565,0000.20%
DISCIPLINED GROWTH INVESTORS INC /MN 689,899$10,438,0000.20%
View complete list of CARA THERAPEUTICS INC shareholders